US 10238642
Methods for treating neurogenic orthostatic hypotension
granted A61KA61K31/165A61K31/198
Quick answer
US patent 10238642 (Methods for treating neurogenic orthostatic hypotension) held by Theravance Biopharma R&D IP, LLC expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/165, A61K31/198, A61K31/4425, A61K31/4465